DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Cheng AL, Kang YK, Chen Z. et al.
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Lancet Oncol 2009;
10 (01) 25-34
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.